Skip to main content
Clinical Trials/NCT03825575
NCT03825575
Recruiting
Not Applicable

Sacral Neuromodulation as Treatment for Fecal Incontinence

McMaster University1 site in 1 country20 target enrollmentSeptember 8, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fecal Incontinence
Sponsor
McMaster University
Enrollment
20
Locations
1
Primary Endpoint
Change in number of fecal incontinence episodes
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

The objective of this study is to investigate if low level laser therapy will do more good than harm for patients with severe refractory fecal incontinence. It is a proof of concept study without a placebo arm.

Detailed Description

The therapy consists of a 3 week treatment with a total of 8 sessions of low level laser therapy. Effects will be assessed using symptoms and quality of life questionnaires and physiological assessments of pelvic floor function, at 4 weeks and 12 weeks after beginning of treatment.

Registry
clinicaltrials.gov
Start Date
September 8, 2019
End Date
February 1, 2027
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jihong Chen

Assistant Professor

McMaster University

Eligibility Criteria

Inclusion Criteria

  • Patients with fecal incontinence

Exclusion Criteria

  • Pregnant patients
  • Known malignancies in the area of treatment
  • Active bleeding in area of treatment
  • Active deep vein thrombosis
  • When tatoos are present at area of treatment
  • Patients that are light sensitive
  • Patients who take steroids.

Outcomes

Primary Outcomes

Change in number of fecal incontinence episodes

Time Frame: 4 weeks and 12 weeks

Number of fecal incontinence episodes per week

Secondary Outcomes

  • Change in anal sphincter tone(12 weeks)
  • Change in increase of anal sphincter pressure during squeezing(12 weeks)
  • Change in squeezing duration(12 weeks)
  • Change in Quality of Life(4 weeks and 12 weeks)
  • Change in symptoms score(4 and 12 weeks)

Study Sites (1)

Loading locations...

Similar Trials